securities violation

9 articles
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Nano-X Imaging Under Fire: Schall Law Firm Launches Fraud Investigation Into $NNOX

Schall Law Firm launches fraud investigation into Nano-X Imaging ($NNOX) following $17.5M impairment charge and CFO departure that triggered 25% stock decline.
NNOXstock declineshareholder lawsuit
BenzingaBenzinga··Schall Law Firm

G-III Apparel Faces Securities Fraud Investigation as Sales Plunge 8.1%

G-III Apparel faces securities fraud investigation after Q4 2026 net sales plunged 8.1%, causing stock to fall 12%.
GIIIclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

BitGo Stock Plunges 16% Amid Earnings Collapse and Securities Investigation

BitGo Holdings ($BTGO) faces securities probe after swinging from $156.6M profit to $14.8M loss, triggering sharp stock decline.
BTGOclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Navan Stock Crashes 63% as Class Action Alleges IPO Disclosure Failures

Class action lawsuit filed against $NAVN for allegedly concealing 39% post-IPO sales expense increase, triggering 12% drop and 63% decline from IPO price.
NAVNclass action lawsuitstock price decline
BenzingaBenzinga··Schall Law Firm

Theravance Biopharma Faces Securities Fraud Investigation Over Failed CYPRESS Trial

Law firm investigating $TBPH for alleged misleading statements about CYPRESS trial and cash burn during enrollment phase that preceded trial failure.
TBPHclass action lawsuitmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Navan Stock Crashes 63% on Undisclosed Expense Plan; Class Action Lawsuit Filed

Class action lawsuit filed against $NAVN over allegedly misleading IPO documents. Stock dropped 63% after company failed to disclose planned 39% sales/marketing expense increase.
NAVNclass action lawsuitstock decline
BenzingaBenzinga··Schall Law Firm

Neumora Therapeutics Faces Securities Fraud Investigation Over Disclosure Violations

The Schall Law Firm investigates Neumora Therapeutics ($NMRA) for potential securities fraud involving false statements or material information omissions.
NMRAclass action lawsuitshareholder rights
BenzingaBenzinga··Business Wire

Driven Brands Faces Securities Investigation After 30% Stock Plunge on Accounting Errors

Schall Law Firm investigates $DRVN for securities violations following material financial restatements. Stock tumbled 30% as company delays earnings release.
DRVNstock declineshareholder litigation
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Navan Class Action Seeks Lead Plaintiffs Over Alleged IPO Disclosure Failures

Navan faces class action lawsuit over alleged IPO disclosure failures regarding undisclosed marketing spending plans. Stock plunged 63% after December earnings announcement revealed 39% expense increase.
NAVNclass action lawsuitstock price decline